nedaplatin has been researched along with Female Genital Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirasawa, N; Ikeda, M; Ishigaki, T; Itoh, Y; Kubota, S; Murao, T; Naganawa, S; Okada, T; Okuda, T | 1 |
| Araki, R; Itoh, A; Iwamizu, H; Kataoka, T; Kawarada, Y; Kumakura, Y; Miyazaki, M; Nagai, T; Ota, A; Yamada, K | 1 |
| Fujiwara, H; Harada, T; Itamochi, H; Kigawa, J; Machida, S; Oishi, T; Sato, S; Shimada, M; Suzuki, M; Takei, Y | 1 |
| Matsumoto, K; Michikami, H; Minaguchi, T; Ochi, H; Okada, S; Oki, A; Onuki, M; Satoh, T; Yoshikawa, H | 1 |
| Adachi, K; Arimoto, T; Kawana, K; Kozuma, S; Matsumoto, Y; Nakagawa, S; Oda, K; Taketani, Y; Tsukazaki, T; Yano, T | 1 |
| Fukuda, T; Hashiguchi, Y; Ichimura, T; Ishiko, O; Kitada, K; Matsumoto, Y; Sumi, T; Yasui, T; Yoshida, H | 1 |
| Fukushima, H; Hirasawa, N; Ishigaki, T; Ishihara, S; Itoh, Y; Iwata, M; Kawase, S; Kumada, S; Mori, Y; Nakamura, T; Okuda, T; Ota, T; Satoh, C; Suzuki, K; Takai, K; Yanagawa, S | 1 |
| Ota, K | 1 |
| Sugiyama, T; Ushijima, K; Yakushiji, M | 1 |
| Horiuchi, M; Miyake, H; Ota, K | 1 |
| Nishimura, H; Yakushiji, M | 1 |
2 review(s) available for nedaplatin and Female Genital Neoplasms
| Article | Year |
|---|---|
[Nedaplatin].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Remission Induction; Urogenital Neoplasms; Vindesine | 1996 |
[Promising new drugs for gynecological cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase I as Topic; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Irinotecan; Organoplatinum Compounds; Paclitaxel; Taxoids; Topotecan | 1997 |
3 trial(s) available for nedaplatin and Female Genital Neoplasms
| Article | Year |
|---|---|
Area under the curve calculation of nedaplatin dose used in combination chemotherapy with irinotecan in a phase I study of gynecologic malignancies.
Topics: Adult; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Camptothecin; Dose-Response Relationship, Drug; Female; Genetic Variation; Genital Neoplasms, Female; Glucuronosyltransferase; Humans; Irinotecan; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds | 2012 |
[Ototoxicity of cis-diammine glycolato platinum, 254-S].
Topics: Aged; Antineoplastic Agents; Audiometry; Cisplatin; Drug Evaluation; Female; Genital Neoplasms, Female; Head and Neck Neoplasms; Hearing; Humans; Kidney; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Prostatic Neoplasms; Urinary Bladder Neoplasms | 1992 |
[Current status of CDDP analogs in gynecologic malignancies].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Doxorubicin; Drug Evaluation; Female; Genital Neoplasms, Female; Humans; Japan; Middle Aged; Multicenter Studies as Topic; Organoplatinum Compounds; Ovarian Neoplasms; Remission Induction; Uterine Cervical Neoplasms | 1989 |
6 other study(ies) available for nedaplatin and Female Genital Neoplasms
| Article | Year |
|---|---|
Retrospective case series of 15 patients treated with chemoradiation using 5-FU and nedaplatin for gynecological malignancy: with regard to hemotoxicity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemoradiotherapy; Female; Fluorouracil; Genital Neoplasms, Female; Hemoglobins; Humans; Leukocyte Count; Middle Aged; Organoplatinum Compounds; Platelet Count; Retrospective Studies; Treatment Outcome | 2014 |
Incidence of and risk factors associated with nedaplatin-related hypersensitivity reactions.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Logistic Models; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Risk Factors | 2017 |
Safety and efficacy of substituting nedaplatin after carboplatin hypersensitivity reactions in gynecologic malignancies.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Female; Genital Neoplasms, Female; Humans; Hypersensitivity; Middle Aged; Organoplatinum Compounds; Treatment Outcome | 2013 |
Retreatment with nedaplatin in patients with recurrent gynecological cancer after the development of hypersensitivity reaction to carboplatin.
Topics: Aged; Antineoplastic Agents; Carboplatin; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Retreatment; Retrospective Studies; Treatment Outcome | 2013 |
Chemotherapy-related hypersensitivity reaction in Japanese patients with gynecologic malignancy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bridged-Ring Compounds; Carboplatin; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Japan; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Taxoids; Young Adult | 2012 |
[Chemoradiation using 5-fluorouracil (5-FU) and nedaplatin (NDP) for gynecological malignancy--the relation between hemotoxicity and sequence of 5-FU and NDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Genital Neoplasms, Female; Hemoglobins; Humans; Middle Aged; Organoplatinum Compounds; Thrombocytopenia | 2004 |